Factors Associated With Extraintestinal Manifestations of Inflammatory Bowel Disease in SPARC-IBD

被引:4
|
作者
Alizadeh, Madeline [1 ,2 ]
Motwani, Kiran [2 ]
Siaton, Bernadette C. [3 ]
Abutaleb, Ameer [4 ]
Ravel, Jacques [1 ]
Cross, Raymond K. [2 ]
机构
[1] Univ Maryland, Inst Genome Sci, Sch Med, Baltimore, MD 21201 USA
[2] Univ Maryland, Sch Med, Dept Med, Div Gastroenterol & Hepatol, Baltimore, MD 21201 USA
[3] Univ Maryland, Sch Med, Dept Med, Div Rheumatol & Clin Immunol, Baltimore, MD USA
[4] George Washington Univ, Sch Med & Hlth Sci, Dept Surg, Washington, DC USA
关键词
inflammatory bowel disease; extraintestinal manifestations; SPARC; CLINICAL-FEATURES; RISK-FACTORS;
D O I
10.1093/ibd/izad280
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Extraintestinal manifestations (EIMs) of inflammatory bowel diseases (IBDs) are a common and debilitating feature of disease, occurring in up to 40% of patients with IBD, yet predicting who may develop them is difficult. The goal of our study was to better characterize which patients may be at highest risk of developing not only 1 EIM, but also multiple EIMs, across both diseases.Methods A retrospective study of participants enrolled in the SPARC IBD (Study of Prospective Adult Research Cohort with IBD) registry was performed, and demographic and clinical data were analyzed. A total of 1211 patients with data available on EIMs were included, and differences among variables with vs without EIMs were assessed.Results A total of 329 participants with at least 1 EIM were identified, compared with 882 participants without any EIMs. Crohn's disease patients and women were more likely to have 2 or more EIMs (P = .005 and P <= .001, respectively). Participants with ocular manifestations were likeliest to have at least 2 EIMs (P <= .001). Even when diagnosis was controlled for, involvement of the right colon (P = .021) was predictive of IBD-associated arthritis across both diseases in a multivariate generalized linear model.Conclusions This is the first comprehensive large-cohort assessment of how EIMs relate to one another at the individual vs systems levels. Further, our analysis is the first to recognize specific locations of colon involvement associated with EIMs of IBD, regardless of IBD type. These results are important in identifying patients at risk of developing future EIMs and may help with risk stratification when choosing treatments. Although extraintestinal manifestations frequently complicate inflammatory bowel disease, predicting those at highest risk of developing them is difficult. We found female patients with Crohn's disease, ocular, and dermatologic manifestations are likeliest to develop multiple extraintestinal manifestations. Further, we found right-sided involvement is predictive of inflammatory bowel disease-associated arthritis.
引用
收藏
页码:2027 / 2036
页数:10
相关论文
共 50 条
  • [41] EXTRAINTESTINAL AND SYSTEMIC MANIFESTATIONS OF INFLAMMATORY BOWEL-DISEASE
    RANKIN, GB
    MEDICAL CLINICS OF NORTH AMERICA, 1990, 74 (01) : 39 - 50
  • [42] Therapies in Inflammatory Bowel Disease Patients with Extraintestinal Manifestations
    Juillerat, Pascal
    Manz, Michael
    Sauter, Bernhard
    Zeitz, Jonas
    Vavricka, Stephan R.
    DIGESTION, 2020, 101 (SUPPL 1) : 83 - 97
  • [43] Extraintestinal Manifestations in Children Diagnosed with Inflammatory Bowel Disease
    Kavcar, Zubeyr
    Civan, Hasret Ayyildiz
    Taskin, Didem Gulcu
    Hatipoglu, Sadik Sami
    MEDICAL BULLETIN OF SISLI ETFAL HOSPITAL, 2023, 57 (01): : 73 - 78
  • [44] EFFECTS OF VEDOLIZUMAB ON EXTRAINTESTINAL MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASE
    Dimopoulos, Christina
    Hung, Kenneth
    Proctor, Deborah
    Ruggiero, Eilzabeth
    Al-Bawardy, Badr
    INFLAMMATORY BOWEL DISEASES, 2020, 26 : S19 - S20
  • [45] Ustekinumab and vedolizumab for extraintestinal manifestations in inflammatory bowel disease
    Livne-Margolin, M.
    Ling, D.
    Konyo, S. Attia
    Haj, O.
    Abitbol, C. M.
    Ben-Horin, S.
    Kopylov, U.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I429 - I430
  • [46] Efficacy of infliximab for extraintestinal manifestations of inflammatory bowel disease
    Siemanowski B.
    Regueiro M.
    Current Treatment Options in Gastroenterology, 2007, 10 (3) : 178 - 184
  • [47] Age at disease onset of inflammatory bowel disease is associated with later extraintestinal manifestations and complications
    Herzog, Denise
    Fournier, Nicolas
    Buehr, Patrick
    Rueger, Vanessa
    Koller, Rebekka
    Heyland, Klaas
    Nydegger, Andreas
    Spalinger, Johannes
    Schibli, Susanne
    Petit, Laetitia-Marie
    Braegger, Christian P.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 30 (06) : 598 - 607
  • [48] EXTRAINTESTINAL MANIFESTATIONS OF INFLAMMATORY BOWEL-DISEASE IN CHILDREN
    HYAMS, JS
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 1994, 19 (01): : 7 - 21
  • [49] Extraintestinal Manifestations of Inflammatory Bowel Disease and the Influence of Smoking
    Roberts, Henry
    Rai, Shesh N.
    Pan, Jianmin
    Rao, J. Michael
    Keskey, Robert C.
    Kanaan, Ziad
    Short, Ethan P.
    Mottern, Edward
    Galandiuk, Susan
    DIGESTION, 2014, 90 (02) : 122 - 129
  • [50] Treatment of the extraintestinal manifestations of inflammatory bowel disease.
    Bernstein C.N.
    Current Gastroenterology Reports, 2002, 4 (6) : 513 - 516